Loading...
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients
In this phase II trial, carboplatin with nanoparticle albumin-bound (nab)-paclitaxel as first-line therapy for advanced non–small-cell lung cancer (NSCLC) was evaluated. Most patients had squamous cell histology. Tumor-associated stromal caveolin-1 (Cav-1) expression was correlated with improved res...
Saved in:
| Published in: | Clin Lung Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5076571/ https://ncbi.nlm.nih.gov/pubmed/26123189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2015.05.004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|